TME three-lens brief
Evidence-based stock research on TME. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 38.9pp over 30 days. · Trading at 3% of its 52-week range — deep in the lower band.
- Trading at 3% of its 52-week range — deep in the lower band.
- Underperforming SPY by 38.9pp over 30 days.
- P/E of 9.0 — trading at a value multiple.
- Analyst mean target $17.56 — 88% above current (29 analysts).
- Debt-to-equity of 4.6 — balance-sheet-heavy.
TME closed at $9.34 (+0.97%) as of 2026-04-25. Market cap: $14.72B. P/E (trailing) 9.0. Positives: p/E of 9.0 — trading at a value multiple.; analyst mean target $17.56 — 88% above current (29 analysts).. Concerns: trading at 3% of its 52-week range — deep in the lower band.; underperforming SPY by 38.9pp over 30 days.. Last quarter: Revenue $8.64B, net income $2.20B, free cash flow $6.28B.
Why three lenses on TME, not one.
A single reasoning model has blind spots it doesn’t know about. We examine TMEacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/TME" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath TME brief"></iframe>